EPO Patents = 3

Forward Citations = 0

Loading Chart...

11 inventors (with patents filed for the assignee):

Peter Rands (6 out of 14 patents)

Zelah Joel (6 out of 12 patents)

Tiffanie Benway (6 out of 12 patents)

4. Marie Claire Layzell (4 out of 9 patents)

5. Ellen James (3 out of 6 patents)

6. George Knight (2 out of 4 patents)

7. Richard Chubb (2 out of 4 patents)

8. Derek Londesbrough (2 out of 4 patents)

9. James Maxwell Rennie (1 out of 2 patents)

10. Meghan Good (1 out of 1 patent)

11. Carol Routledge (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 12343327 - Injectable formulations (2025-07-01),

2. 12318477 - Injectable and inhalable formulations (2025-06-03),

3. 12251371 - Deuterated or partially deuterated N,N-dimethyltryptamine compounds (2025-03-18),

4. 12157723 - Compounds (2024-12-03),

5. 12084417 - Synthesis of N,N-dimethyltryptamine-type compounds, methods, and uses (2024-09-10),

6. 12076311 - Therapeutic compositions comprising deuterated or partially deuterated N,N-dimethyltryptamine compounds (2024-09-03),

7. 12042564 - Therapeutic solid dosage forms (2024-07-23),

Cybin UK Ltd is a biotechnology company focused on developing innovative psychedelic-based treatments for mental health disorders. Leveraging advanced drug delivery mechanisms and treatment methodologies, Cybin aims to address the unmet medical needs of patients suffering from various psychological conditions. The company is committed to promoting mental wellness through rigorous research, development, and collaboration within the growing field of psychedelic medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

7 Patents

#389 in London

#2,298 in United Kingdom

London, United Kingdom

Cybin UK Ltd